Breaking News Instant updates and real-time market news.

BLCM

Bellicum Pharmaceuticals

$6.05

0.22 (3.77%)

16:57
08/07/18
08/07
16:57
08/07/18
16:57

Bellicum Pharmaceuticals files $150M mixed securities shelf

  • 07

    Aug

BLCM Bellicum Pharmaceuticals
$6.05

0.22 (3.77%)

04/11/18
WELS
04/11/18
UPGRADE
WELS
Outperform
Bellicum Pharmaceuticals upgraded to Outperform at Wells Fargo
04/12/18
CANT
04/12/18
NO CHANGE
Target $18
CANT
Overweight
Bellicum price target raised to $18 from $10 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for Bellicum Pharmaceuticals to $18 following the announcement of the FDA's lift of its U.S. clinical hold for BPX-501. The analyst now has increased confidence across the BPX-501 platform. He reiterates an Overweight rating on the shares.
04/12/18
WELS
04/12/18
UPGRADE
Target $23
WELS
Outperform
Wells Fargo upgrades Bellicum to Outperform on lifting of clinical hold
Wells Fargo analyst Jim Birchenough last night upgraded Bellicum Pharmaceuticals to Outperform from Market Perform and raised his price target for the shares to $23 from $6. The shares in premarket trading are up 27% to $8.70 following news that the FDA lifted the clinical hold on studies of BPX-501 in the U.S. Rapid resolution of the clinical hold "substantially de-risks the investment," Birchenough tells investors in a research note. He believes Bellicum's platform for controllable cell therapies is well positioned for therapeutic oncology indications.
03/14/18
JEFF
03/14/18
NO CHANGE
Target $16
JEFF
Buy
Bellicum clinical hold should lift soon, says Jefferies
Jefferies analyst Biren Amin says Bellicum Pharmaceuticals last night provided an update of its leading prgm BPX-501 with an "encouraging" survival rate at one year in pediatric acute myeloid leukemia patients. For BPX-601, management reported CART cell expansion in one pancreatic cancer patient following rimiducid administration, providing first patient validation of the company's activation switch, Amin tells investors in a post-earnings research note. The analyst notes Bellicum has also responded to FDA including proposed protocol changes. Amin believes the clinical hold should lift soon and keeps a Buy rating on Bellicum Pharmaceuticals with a $16 price target.

TODAY'S FREE FLY STORIES

09:25
06/27/19
06/27
09:25
06/27/19
09:25
General news
The U.S. Q1 GDP data »

The U.S. Q1 GDP data…

09:25
06/27/19
06/27
09:25
06/27/19
09:25
Conference/Events
Morgan Stanley LatAm analysts to hold an analyst/industry conference call »

LatAm Agribusiness…

RHHBY

Roche

$0.00

(0.00%)

09:25
06/27/19
06/27
09:25
06/27/19
09:25
Conference/Events
Wolfe Research pharma analyst to hold an analyst/industry conference call »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 03

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 04

    Nov

RHHBY

Roche

$0.00

(0.00%)

09:25
06/27/19
06/27
09:25
06/27/19
09:25
Conference/Events
Wolfe Research pharmaceuticals analyst to hold analyst/industry conference call »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 03

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 04

    Nov

09:25
06/27/19
06/27
09:25
06/27/19
09:25
Conference/Events
Cantor Fitzgerald tech services analyst to hold analyst/industry conference call »

Analysts Kootman and…

BNS

Bank of Nova Scotia

$54.22

0.05 (0.09%)

, OFG

OFG Bancorp

$20.68

0.305 (1.50%)

09:25
06/27/19
06/27
09:25
06/27/19
09:25
Conference/Events
OFG Bancorp to hold a conference call »

OFG Bancorp holds a…

BNS

Bank of Nova Scotia

$54.22

0.05 (0.09%)

OFG

OFG Bancorp

$20.68

0.305 (1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Aug

CETX

Cemtrex

$1.86

-0.445 (-19.35%)

09:22
06/27/19
06/27
09:22
06/27/19
09:22
Hot Stocks
Cemtrex EMS segment receives $6M in new orders »

Cemtrex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$275.47

0.11 (0.04%)

09:21
06/27/19
06/27
09:21
06/27/19
09:21
Recommendations
ServiceNow analyst commentary  »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$25.76

0.25 (0.98%)

09:20
06/27/19
06/27
09:20
06/27/19
09:20
Syndicate
BJ's Wholesale 9.98M share Spot Secondary priced at $25.74 »

Goldman Sachs acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

DSX

Diana Shipping

$3.30

0.01 (0.30%)

09:19
06/27/19
06/27
09:19
06/27/19
09:19
Hot Stocks
Diana Shipping announces time charter contract for m/v Semirio »

Diana Shipping announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCBS

Nicolet Bankshares

$60.99

-1.02 (-1.64%)

09:18
06/27/19
06/27
09:18
06/27/19
09:18
Hot Stocks
Nicolet Bankshares to acquire Choice Bancorp »

Nicolet Bankshares and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
06/27/19
06/27
09:18
06/27/19
09:18
Options
Overnight activity included 325 trades in SPX and 8 trades in VIX »

325 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INMB

INmune Bio

$8.95

0.05 (0.56%)

09:17
06/27/19
06/27
09:17
06/27/19
09:17
Hot Stocks
INmune Bio announces publication of data on INKmune Primed NK cells »

INmune Bio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNRC

Generac

$68.50

-0.335 (-0.49%)

09:15
06/27/19
06/27
09:15
06/27/19
09:15
Recommendations
Generac analyst commentary  »

Generac price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRP

TC Pipeline

$48.93

0.15 (0.31%)

09:15
06/27/19
06/27
09:15
06/27/19
09:15
Hot Stocks
TC Energy launches binding open season for Keystone Pipeline System »

TC Energy Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$76.59

0.31 (0.41%)

09:15
06/27/19
06/27
09:15
06/27/19
09:15
Hot Stocks
Exxon Mobil, Global Thermostat to develop carbon dioxide capturing technology »

Exxon Mobil and Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:15
06/27/19
06/27
09:15
06/27/19
09:15
General news
The unrevised 3.1% U.S. Q1 GDP growth figure »

The unrevised 3.1% U.S.…

VISI

Volt Information Sciences

$4.40

0.12 (2.80%)

09:14
06/27/19
06/27
09:14
06/27/19
09:14
Hot Stocks
Volt Information Sciences names Lori Schultz Chief Global Solutions Officer »

Volt Information Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$53.61

-0.41 (-0.76%)

09:14
06/27/19
06/27
09:14
06/27/19
09:14
Hot Stocks
DXC Technology, Zafin partner to help banks manage conduct risk »

DXC Technology and Zafin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWAY

Brainsway

$10.21

-0.08 (-0.78%)

09:13
06/27/19
06/27
09:13
06/27/19
09:13
Hot Stocks
Psychiatrist debuts BrainsWay's FDA-cleared treatment for MDD, OCD »

Dr. Fabian Carbonell is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$86.15

1.27 (1.50%)

, VZ

Verizon

$57.00

-1.01 (-1.74%)

09:10
06/27/19
06/27
09:10
06/27/19
09:10
Hot Stocks
Zoom Video, Verizon partner for unified communications solution »

Verizon Business Group…

ZM

Zoom Video

$86.15

1.27 (1.50%)

VZ

Verizon

$57.00

-1.01 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

BASFY

BASF

$0.00

(0.00%)

09:10
06/27/19
06/27
09:10
06/27/19
09:10
Hot Stocks
BASF announces restructuring, to cut 6,000 positions by end of 2021 »

BASF announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

09:10
06/27/19
06/27
09:10
06/27/19
09:10
General news
U.S. equities have trimmed overnight gains »

U.S. equities have…

ASV

ASV Holdings

$1.64

-0.11 (-6.29%)

, TEX

Terex

$30.76

-0.245 (-0.79%)

09:09
06/27/19
06/27
09:09
06/27/19
09:09
Hot Stocks
ASV Holdings enters definitive merger agreement with Yanmar affiliate »

ASV Holdings (ASV)…

ASV

ASV Holdings

$1.64

-0.11 (-6.29%)

TEX

Terex

$30.76

-0.245 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$54.21

-1.01 (-1.83%)

09:08
06/27/19
06/27
09:08
06/27/19
09:08
Hot Stocks
Mondelez announces renewable energy partnership with Enel Green Power »

Mondelez International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.